Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term quantification. Found 13 abstracts

Booij J, Dubroff J, Pryma D, Yu J, Agarwal R, Lakhani P, Kuo PH. Diagnostic performance of the visual reading of 123I-ioflupane SPECT images when assessed with or without quantification in patients with movement disorders or dementia. J Nucl Med. 2017 Nov;58(11):1821-6.
Weber WA, Gatsonis CA, Mozley PD, Hanna LG, Shields AF, Aberle DR, Govindan R, Torigan DA, Karp JS, Yu JQ, Subramaniam RM, Halvorsen RA, Siegel BA. Repeatability of 18F-FDG PET/CT in Advanced Non-small Cell Lung Cancer: Prospective Assessment in Two Multicenter Trials. J Nucl Med. 2015 Apr 23;56(8):1137-43.   PMCID: 4699428
Hyslop T, Weinberg DS, Schulz S, Barkun A, Waldman SA. Occult Tumor Burden Predicts Disease Recurrence in Lymph Node-Negative Colorectal Cancer. Clinical Cancer Research. 2011 May;17(10):3293-303.   PMCID: PMC3096730
Kamat AA, Baldwin M, Urbauer D, Dang D, Han LY, Godwin A, Karlan BY, Simpson JL, Gershenson DM, Coleman RL, Bischoff FZ, Sood AK. Plasma Cell-Free DNA in Ovarian Cancer An Independent Prognostic Biomarker. Cancer. 2010 Apr;116(8):1918-25.   PMCID: PMC2854845
Li BS, Wang H, Gonen O. Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy. Magnetic Resonance Imaging. 2003 Oct;21(8):923-8.
Ge Y, Grossman RI, Udupa JK, Fulton J, Constantinescu CS, Gonzales-Scarano F, Babb JS, Mannon LJ, Kolson DL, Cohen JA. Glatiramer acetate (Copaxone) treatment in relapsing-remitting MS - Quantitative MR assessment. Neurology. 2000 Feb 22;54(4):813-7.
Saindane AM, Ge Y, Udupa JK, Babb JS, Mannon LJ, Grossman RI. The effect of gadolinium-enhancing lesions on whole brain atrophy in relapsing-remitting MS. Neurology. 2000 Jul 12;55(1):61-5.
Gonen O, Viswanathan AK, Catalaa I, Babb J, Udupa J, Grossman RI. Total brain N-acetylaspartate concentration in normal, age- grouped females: Quantitation with non-echo proton NMR spectroscopy. Magnetic Resonance in Medicine. 1998 Nov;40(5):684-9.
Murphy-Boesch J, Jiang H, Stoyanova R, Brown TR. Quantification of phosphorus metabolites from chemical shift imaging spectra with corrections for point spread effects and B-1 inhomogeneity. Magnetic Resonance in Medicine. 1998 Mar;39(3):429-38.
Kuesel AC, Stoyanova R, Aiken NR, Li CW, Szwergold BS, Shaller C, Brown TR. Quantitation of resonances in biological P-31 NMR spectra via principal component analysis: Potential and limitations. Nmr in Biomedicine. 1996 May;9(3):93-104.
Murphyboesch J, Stoyanova R, Srinivasan R, Willard T, Vigneron D, Nelson S, Taylor JS, Brown TR. Proton-Decoupled P-31 Chemical-Shift Imaging of the Human Brain in Normal Volunteers. Nmr in Biomedicine. 1993 May;6(3):173-80.
Nelson SJ, Vigneron DB, Brown TR. Detection of Significant Features and Statistical-Analysis of 2d and 3d Images of P-31 Metabolites. Magnetic Resonance in Medicine. 1992 May;25(1):85-93.
Nelson SJ, Taylor JS, Vigneron DB, Murphyboesch J, Brown TR. Metabolite Images of the Human Arm - Changes in Spatial and Temporal Distribution of High-Energy Phosphates During Exercise. Nmr in Biomedicine. 1991 Dec;4(6):268-73.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term quantification

quantification spectra quantitation invivo disease- disability human-brain marker nmr-spectroscopy activity nuclear magnetic-resonance brain fuzzy-connectedness p-31 nmr domain phosphorus metabolites skeletal-muscle resonance serial magnetic-resonance repeatability colon-cancer 1 mr spectroscopy spinal-cord atrophy guanylyl cyclase-c benign lattice relaxation-times recommendations h-1-nmr spectra white matter mri to-noise ratio in-vivo recognition segmentation adjuvant chemotherapy therapy micrometastases magnetic resonance spectroscopy MULTIPLE-SCLEROSIS barr-virus dna Fdg pet 123I-ioflupane SPECT Neurology confidence-intervals progressive multiple-sclerosis MR magnetic-resonance spectroscopy N-ACETYL ASPARTATE DISABILITY nuclear-magnetic-resonance SPECTRA placebo-controlled trial appearing white-matter N-acetylaspartate Other human calf real-time polymerase chain reaction cell-free DNA-prognosis-ovarian cancer-biomarker glatiramer acetate nasopharyngeal carcinoma KeyWords Plus: spectroscopy relapsing-remitting MS REPRODUCIBILITY CHOLINE pattern- signal enhancing lesions metabolite concentration Spect volume measurement h-1 spectra time metabolite-ratio proton MR spectroscopy (H-1-MRS) visual interpretation lung-cancer magnetic- metabolism circulating dna messenger-rna movement disorders classification ct Pet principles expanded disability chemical shift imaging WHITE-MATTER dementia SCHIZOPHRENIA muscle suppression sequence serum dna h- mr spectroscopy proton spectroscopy high-energy phosphates multiple-sclerosis metabolites LESIONS resonance-imaging lesions reproducibility multiple-sclerosis lesions images status scale score Oncology: Lung double-blind MAGNETIC-RESONANCE SPECTROSCOPY surface-coil nmr
Last updated on Sunday, July 05, 2020